Benefit Evaluation in Vitiligo Treatment: Development and Validation of a Patient-Defined Outcome Questionnaire

Publisher： Karger

E-ISSN： 1421-9832|217|2|101-106

ISSN： 1018-8665

Source： Dermatology, Vol.217, Iss.2, 2008-05, pp. : 101-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health-Related Quality of Life and Patient-Defined Benefit of Clobetasol 0.05% in Women with Chronic Lichen Sclerosus of the Vulva

By  

Dermatology, Vol. 223, Iss. 2, 2011-10 ,pp. : 152-160

Karger

Access to resources Recommend Favorite

Assessing the Value of Supportive Skin Care: Development and Validation of an Instrument for Evaluating Patient-Relevant Benefit

By  

Dermatology, Vol. 218, Iss. 3, 2009-01 ,pp. : 255-259

Karger

Access to resources Recommend Favorite

Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study

By  

Dermatology, Vol. 232, Iss. 3, 2016-04 ,pp. : 334-343

Karger

Access to resources Recommend Favorite

Etanercept in the Treatment of Vitiligo

By  

Dermatology, Vol. 215, Iss. 1, 2007-06 ,pp. : 84-85

Karger

Access to resources Recommend Favorite

Development of a Quality of Life Scale for Vitiligo

By  

Dermatology, Vol. 226, Iss. 2, 2013-05 ,pp. : 185-190

Karger

Access to resources Recommend Favorite